A human genetics investigator discusses new RNA research developments that may aid in treating and preventing rare genetic diseases.
70% of spending on “partial orphan” drugs – those approved to treat both rare and common diseases – goes toward treatment of common diseases.
Many take leftover doses from previous prescriptions, and expect new prescriptions for non-bacterial illness.
A new survey shows high usage rates of cannabinoids like CBD for multiple sclerosis, but most patients are figuring out these new products on their own.
“Secret shopper” study finds stigma is highest against those who say their last doctor stopped prescribing opioids to them.
National Research Effort Discovers Relationship Between Inflammation, Metabolism and Scleroderma Scarring
Study finds NAD+ break down leads to multi organ scarring, providing now a previously undiscovered pathogenic role of the enzyme CD38 in disease scarring.